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ABSTRACT 
Objective: The objective of the present study was to formulate sustained release glipizide loaded microspheres and evaluate the effect of 
various variables on their properties.  
Materials and Methods: The microspheres were prepared by non-solvent addition coacervation method. Ethyl cellulose used as a polymer, 
petroleum ether (60-40º) for induced coacervation and n-hexane as non-solvent for microspheres preparation. 
Results: Microspheres were characterized in term of percent yield, percent entrapment and release pattern of drug. The shape, color an d 
particle size of microspheres were also evaluated. According the result of formulation, n-hexane used as non solvent resulted in enhances 
rigidization of coating and petroleum ether (60-40º) for induced coacervation. The maximum percent yield of GEN6 formulation was 75.7; 
particle size in the range of 50-450 µ, maximum entrapment was 89.8 ± 0.11% for GEN3 formulation. GEN1 formulation with low polymer ratio 
showed better in-vitro release between 95-100%.  Formulation GEN4 showed 40-50% reduction in plasma glucose level than conventional 
dosage forms when tested in-vivo. 
Conclussion: Result of the present study supported that the formulation showed sustenance release with the potential application of n-hexane 
for improving the physical properties as well as the release profile of this water insoluble drug.  
Keywords: Glipizide, sustained release, ethyl cellulose, n-hexane, petroleum ether (60-40º), in-vivo & in-vitro. 
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INTRODUCTION 
Diabetes Mellitus (DM) is a chronic metabolic disorder 
affecting people worldwide, with significant morbidity and 
mortality caused by its micro-vascular and macro-vascular 
complications, affecting various vital organs and structures 
in humans 1. It has been estimated that by year 2030, the 
diabetic population will rapidly increase in India. However, 
prevalence is much more, as many patients are 
asymptomatic and go undiagnosed. 
The drug delivery systems that can precisely control the 
release rates or target drugs to specific body site have an 
enormous impact on the healthcare system. The last two 
decades in the pharmaceutical industry, have witnessed an 
avant-grade interaction among the field of polymer and 
material science, resulting in the development of novel 
drug delivery systems 2,3. Microspheres acquire important 
features among the particulate drug delivery systems by 
virtue of their small size and efficient carrier 
characteristics. However, the success of microspheres 
delivery system is less due to their short residence time at 
the site of absorption.2 The physicochemical 
characteristics of the active chosen vary considerably, so 
microspheres are often developed according to specific 
clinical needs 4,5. Microspheres were prepared by 
Coacervation method for their ease and cost effectiveness 
6. 
Glipizide is an anti-diabetic drug (Fig 1) used to treat type 
II diabetes mellitus. It has a short half life of 2-3 hrs, and 
was easily converted in sustained release formulation to 
reduce dosing frequency. A model dosage form is one, 
which attains the desired therapeutic concentration of 
drug in plasma and maintains it for entire duration of 
treatment. The sustain release formulations of this drug 
results in constant plasma level for up to 24 hrs 7. It is 
extensively metabolized by the liver (90%); and only 10% 
being excreted unchanged by the kidney 8. 
Glipizide is an oral blood-glucose-lowering drug of the 
sulfonylurea class, chemical name is l-cyclohexyl-3-[[p-[2-
(5-methyrpyrazine-carboxamido) 
ethyl]phenyl]sulfonyl]urea. It is a whitish, odorless 
powder, insoluble in water and alcohols, but soluble in 0.1 
N NaOH, and freely soluble in dimethylformamide. Its 
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molecular formula is C21H27N5O4S, molecular weight is 
445.55, melting point is 195-200o and pKa is 5.9. 
 
Figure 1: Chemical structure of Glipizide 
 
In the present investigation, a formulation of glipizide, 
capable of providing detectable blood levels over 10 hrs 
was formulated using expandable, gelling, swellable 
hydrocolloid polymer. 
Ethyl cellulose is a derivative of cellulose in which some of 
the hydroxyl groups on the repeating glucose units are 
converted into ethylether groups. The number of ethyl 
groups can vary depending on the manufacturer. It is 
mainly used as a thin-film coaterial. Ethyl cellulose is used 
as a food additive as an emulsifier. 
MATERIALS AND METHODS 
Materials 
Glipizide was obtained as a gift sample from by Kreative 
Organics, Hyderabad. Ethyl-cellulose was purchased from 
Loba Cheme, Mumbai, India. All other chemicals used were 
of analytical grade.   
Method 
Preparation of microspheres: 
Microspheres were prepared by coacervation method. 
Ethyl cellulose was dissolved in warm toluene to get a 
homogenous solution. Drug added and dispersed 
thoroughly by the vertical mechanical stirrer for 30 min. 
Coacervation was induced by adding petroleum-ether (60-
40º) slowly over a period of 20 min while stirring 
continuously at the same speed (800 rpm) until the coating 
is formed, then n-hexane (non solvent) was added to 
enhance rigidization of coating. The product was filtered, 
air dried and stored in amber colored bottles and kept in 
desiccator until used (Table 1). 
 
Table 1: Composition for glipizide microspheres formulated by coacervation method 
Glipizide Ethyl Cellulose coacervation microspheres 
Code Drug Ethyl Cellulose Toluene  
(350 ml) 
Pet. Ether  
(250 ml) 
N-Hexane D:P 
GEN1 100 mg + + + 100 ml 1:0.5 
GEN2 + + + + + 1:1 
GEN3 + + + + + 1:1.2 
GEN4 + + + + + 1:1.4 
GEN5 + + + + + 1:1.6 
GEN6 + + + + + 1:1.8 
GEN7 + + + + + 1:2 
D:P = Drug to polymer ratio,           + = present. 
Characterization of microspheres 
The prepared microspheres were characterized in terms of 
% yield, particle size distribution, entrapment efficiency, in 
vitro drug release, in vivo drug release etc.  
Percentage yield 
The percentage yield of the microspheres was calculated for 
each batch by dividing the weight of microspheres by the 
total weight of drug and polymer. 
Percentage Yield= practical yield/theoretical yield x 100 
Entrapment efficiency: 
Microspheres were crushed and dissolved in 5 ml acetone. 
The suspention was suitably diluted with water and filtered 
to remove the shell fragments 9. The amount of drug present 
in weighed samples was assayed spectrophotometrically 
(Shimadzu UV 1800) at λ max 276 nm in triplicate (Table 2). 
Drug entrapment efficiency (%) = Calculated drug 
content/theoretical drug content x 100 
Size distribution and size analysis  
Glipizide-ethyl cellulose microspheres were fractionated 
into different sizes by sieving for 10 min using a mechanical 
shaker with standard sieves as per the specifications of The 
Indian Pharmacopoeia. The particle size distribution (Fig 2) 
was determined and means particle size of microspheres 
was calculated by the following formula.   
Mean particle size =
                                                          
                       
   
Eqn.1                                                                                  
Differential scanning calorimetry (DSC) 
Thermograms of drug, polymers and microspheres were 
obtained using Differential Scanning Calorimetry 822e 
(Mettler Toledo) calorimeter. It measures the amount of 
heat energy absorbed or released by a sample, as it is heated, 
cooled or held at a constant temperature (Fig 3). DSC was 
carried out to determine the possible interaction between 
drug and polymers. No interactions were observed and 
individual peaks of the polymers were present in DSC 
thermograms. Extra peaks were of the impurities or solvent 
residues in the formulation. 
In vitro drug release 
The in vitro release studies were carried out at 37 ± 0.5° and 
at 100 rpm by buffer change method using 200 ml pH 1.2 
HCl (1 h), 4 pH (1 h), 6 pH (3 h), 6.8 pH (3 h) and 7.4 pH (2 h) 
phosphate buffers in sink conditions using a Diffusion cell. 
Accurately weighed sample of prepared microspheres were 
added to the donor cell. At pre-set time intervals, 5 ml of 
aliquots were withdrawn and replaced by an equal volume 
of fresh dissolution medium 10-12. The aliquots were 
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analyzed UV spectrophotometrically at λ max 276 nm after 
proper dilution (Fig. 4, Table 3).  
In-vivo Hypogycemic Activity 
In-vivo hypoglycemic activity of Glipizide formulation, in 
normal and hyperglycemic rats 
The in-vivo hypoglycemic activity was conducted in healthy 
and hyperglycemia induced male albino wistar rats of 
175±25 gm body weight by measuring the hyperglycemic 
effect produced after oral administration of the sample dose 
equivalent to 5 mg/ kg body weight of glipizide in 
comparison to pure drug at same dose. The formulations 
were selected based on their in-vitro release profiles. 
All animal experiments were approved by Institutional 
Animal Ethics Committee (IAEC) of Pinnacle Biomedical 
Research Institute (PBRI) Bhopal, (Reg. No. 
1824/PO/ERe/S/15/CPCSEA). Protocol Approval Reference 
No. PBRI/IAEC/PN-16042. Animals were housed in separate 
cages under controlled temperature (22 ± 2°) and provided 
standard diet (Golden feed, New Delhi) and water regularly 
13-15. They were exposed to alternating light and dark cycle 
of 12 hrs each. They were further divided into four groups 
with six animals in each group 16-19 (Table 4). 
Experimentation:  
Animals were divided into four groups with six animals in 
each group. Group I, received normal saline orally only and 
served as vehicle control, Group II made diabetic with 
streptozotocin (STZ). Group III received Glipizide (5 mg/kg) 
per day orally, group IV received formulation GEN4 (5 
mg/kg) per day oral. Dosing of test samples were done orally 
throughout the experimentation (Table 5-6 & Fig 5). 
RESULT AND DISCUSSION 
The physiochemical characteristics of the prepared 
microspheres were showed in Table 2. Microspheres of 
glipizide were formulated using ethyl cellulose by 
coacervation method. Different concentrations of the 
polymer were used to entrap the drug and various process 
variable parameters were analyzed. According the result of 
formulation, n-hexane used as non solvent resulted in 
enhances rigidization of coating and petroleum ether (60-
40º) for induced coacervation. 
 
Table 2: Physicochemical properties of the glipizide ethyl cellulose coacervation microspheres 
Ethyl cellulose non solvent Microspheres of Glipizide 
Code % yield %entrapment ±S.D Shape  Color 
GEN1 68.6 89.5 ± 0.37 spherical White 
GEN2 57.2 87.0 ± 0.55 spherical White 
GEN3 72.0 89.8 ± 0.11 spherical White 
GEN4 62.2 89.7 ± 0.26 spherical White 
GEN5 61.3 80.1 ± 0.15 spherical White 
GEN6 75.7 79.2 ± 0.10 spherical White 
GEN7 72.8 87.0 ± 0.11 spherical White 
 
 
 
Figure 2: Size distribution of glipizide microspheres 
 
Figure 3: DSC graph of glipizide microspheres (Sample 
GEN-6 
 
For preparation of microspheres, a constant speed of 800 
rpm was chosen which aided in the evaporation of solvent 
from polymer solution. Change in temperature did not affect 
the size of microspheres, but the surface characteristics 
were greatly affected. The polymer concentration directly 
affected the morphological and release characteristics of 
formulations. Low polymer concentration lead to uneven 
while high polymer concentrations lead to smooth surfaces 
and even sized microspheres. 
The release of drug from microspheres was fast in case of 
low concentration of polymer and drug release was slow 
when concentration was high. The formulations were white, 
spherical and small in size. Polymer ethyl cellulose is 
insoluble in all physiological pH values but swells at all pH 
conditions.
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Figure 4: In-vitro release graph GEN1-GEN7 
Table 3: In vitro release kinetic equation data of glipizide microspheres 
Sample Code Zero order First order Higuchi Korsmeyer Peppas Hixson Crowell 
 R0 R1 RH RK RHC 
GEN1 0.983 0.848 0.981 0.760 0.962 
GEN2 0.932 0.975 0.930 0.752 0.973 
GEN3 0.938 0.970 0.938 0.777 0.965 
GEN4 0.934 0.959 0.931 0.794 0.959 
GEN5 0.955 0.970 0.950 0.813 0.974 
GEN6 0.977 0.975 0.977 0.888 0.971 
GEN7 0.958 0.938 0.953 0.931 0.946 
R= regression coefficient value 
The polymer ethyl cellulose produced water insoluble layer 
of around the microspheres. It is chemically resistant to 
alkali but in acidic conditions shows high sensitivity. The 
dissolution of microspheres carried out in simulated 
gastrointestinal media showed an initial burst effect due to 
migration of drug towards periphery. A homogenous 
solution of the polymer in toluene was added continuously 
to petroleum ether with stirring. Since the solvents are in 
compatible in nature; hence precipitation of polymer takes 
place on drug particle. The combination produced a rigidized 
film after solvent evaporation by continuous stirring. The 
coat was further hardened by addition of non-solvent, n-
hexane. The release from microspheres was a function of 
polymer wall thickness. The complete drug released within 
10 hrs. 
 
Table 4: For In-vivo grouping of animals 
Group No. Treatment Dose No. of animals 
1 Normal Saline 5 ml/kg p.o. 06 
2 Streptozotocin (STZ control) 60 mg/kg i.p. 06 
3 Glipizide 5 mg/kg p.o. 06 
4 GEN4 5 mg/kg p.o. 06 
 
Statistical analysis of data:  
All data were analyzed by One way ANOVA followed by 
Bonferroni test. p<0.05 was considered as level of 
significance. All data are presented in mean±SD. 
Glipizide showed significant decrease in plasma glucose 
levels in both normal and hyperglycemic rats. 
A 25% reduction in glucose is considered a significant 
hypoglycemic effect. The sustained hypoglycemic effect with 
microspheres is due to the slow release and absorption of 
glipizide over extended periods of time.  
The plasma glucose level of diabetic controlled rats 
increased significantly from day 3 to day 7 of STZ injection. 
Hyperglycemic rats were selected for the study as discussed 
above. The plasma glucose data obtained indicates that the 
drug is entrapped in microspheres & produced consistent 
anti-hyperglycemic effect. This effect was pronounced in 
case of hyperglycemic rats whereas normal rats showed 
comparatively lesser alterations in plasma glucose level after 
formulation administration. 
 
Table 5: Blood Glucose Level (mg/dl)  
S. No. Treatment 0 Day 3 Day 5 Day 7 Day 
1 Normal Saline (5 ml/kg) 87.90±5.626 89.60±5.873 90.48±6.485 89.20±6.429 
2 STZ Control 284.35±11.734 289.43±12.438 293.92±12.020 296.73±11.853 
3 Glipizide (5 mg/kg) 282.93±8.574 222.65±8.025 166.90±8.773 119.43±9.211 
4 GEN4 (5 mg/kg) 284.42±6.205 256.73±6.757 210.33±7.839 156.58±9.295 
        Values are expressed as MEAN±SD at n=6, One way ANNOVA followed by Bonferroni test, *P<0.050                 
        significant compared to the diabetic control group 
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Table 6: Reduction in plasma glucose levels after administration 
Treatment Day 1 Day 3 Day 5 Day 7 
STZ Control group Glipizide 18.101 21.013 40.211 50.874 
Glipizide (5 mg/kg) 18.213 23.072 43.215 59.751 
GEN4 (5 mg/kg) 06.758 11.298 28.439 47.231 
 
 
Figure 5: Percent reduction in plasma glucose level in 
hyperglycemic rats 
 
CONCLUSION    
A new sustained release system of glipizide microspheres of 
ethyl cellulose were designed and formulated by 
coacervation method. It’s morphological and release 
characteristics were studied. The microspheres were easy to 
prepare and the mean diameter of microspheres increased 
with increase in the amount of the polymers increase. The 
pore size of microspheres was affected by concentration of 
the polymer. Stirring at high speed above 800 rpm causes 
destruction of microspheres. The microspheres showed 
excellent in vivo activity and sustained release 
characteristics as compared to the conventional oral dosage 
forms. Thus, drug entrapment technique is a useful tool for 
the development of multi-particulate system even for a 
water-insoluble drug. 
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